Not Yet Recruiting OBSERVATIONAL NCT07124403

DESIR. Evaluation of the Pre-therapeutic Activity of Dihydropyrimidine dEShydrogenase (DPD) in Patients With Cancer and/or Renal Failure (DESIR)

Evaluation of the Pre-therapeutic Activity of Dihydropyrimidine dEShydrogenase (DPD) in Patients With Cancer and/or Renal Failure

Sponsor: Centre Hospitalier Universitaire de Besancon

Conditions Breast Cancer Digestive Cancers Renal Impairment

Interventions Blood sampling blood sampling

Updated 2 times since 2025 Last updated: Sep 11, 2025 Started: Sep 30, 2025 Primary completion: Mar 31, 2028 Completion: Sep 30, 2028

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Breast Cancer and Digestive Cancers and is currently actively recruiting participants. Centre Hospitalier Universitaire de Besancon leads this study, which shows 2 recorded versions since 2025 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

2 versions recorded

Oct 2025 — Present [monthly]

Not Yet Recruiting

Phase: NA → None
Sep 2025 — Oct 2025 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centre Hospitalier Universitaire de Besancon

Data source: Centre Hospitalier Universitaire de Besancon

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.